NUVA
NuVasive, Inc.
Set alert
52-week range unavailable
- Open
- 40.62
- Prev close
- 39.75
- Mkt cap
- 2.26B
- Vol
- 30.59M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 39.51
- High
- 40.96
- Forward P/E
- 16.86
- Beta
- 1.07
- Short ratio
- 10.39
- Inst. own
- 112.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 2, 2023
- 50-d avg
- 40.46
- 200-d avg
- 41.49
- 1y target
- 48.73
Key statistics
- Market cap
- 2.26B
- Enterprise value
- 3.11B
- Trailing P/E
- 107.90
- Forward P/E
- 16.86
- PEG ratio
- 1.05
- Price / sales
- 1.86
- Price / book
- 2.59
- EPS (TTM)
- 0.40
- Beta
- 1.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.66%
- Revenue (TTM)
- 1.22B
- Revenue growth
- 5.80%
- Free cash flow
- 17.42M
- Total cash
- 181.20M
- Total debt
- 1.01B
- Return on equity
- 2.40%
- Shares outstanding
- 52.45M
- Short % of float
- 16.38%
- 50-day average
- 40.46
- 200-day average
- 41.49
Analyst view
Consensus: hold
- Target (low)
- 40.00
- Target (mean)
- 48.73
- Target (high)
- 58.00
- Strong buy6
- Buy7
- Hold4
- Sell1
- Strong sell0
Next earnings
Aug 2, 2023
Expected Aug 2, 2023. Consensus EPS estimate 0.55.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 2, 2023 | Jun 1, 2023 | 0.56 | — | — | — |
| May 10, 2023 | Mar 1, 2023 | 0.41 | — | — | — |
| Feb 22, 2023 | Dec 1, 2022 | 0.49 | — | — | — |
| Nov 9, 2022 | Sep 1, 2022 | 0.53 | — | — | — |
| Aug 3, 2022 | Jun 1, 2022 | 0.55 | — | — | — |
| May 4, 2022 | Mar 1, 2022 | 0.38 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 31, 2023 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| May 15, 2023 | RBC Capital | reit | Outperform | Outperform |
| May 12, 2023 | Barclays | main | Overweight | Overweight |
| May 11, 2023 | RBC Capital | reit | Outperform | Outperform |
| May 11, 2023 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Feb 23, 2023 | JP Morgan | main | — | Neutral |
About NuVasive, Inc.
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nuvasive.com
News
- Earnings Scheduled For August 2, 2023
- Earnings Scheduled For May 10, 2023
- Earnings Scheduled For February 22, 2023
- Stocks That Hit 52-Week Lows On Thursday
- Earnings Scheduled For November 9, 2022
- Stocks That Hit 52-Week Lows On Tuesday
- Stocks That Hit 52-Week Lows On Wednesday
- Earnings Scheduled For August 3, 2022
- Earnings Scheduled For May 4, 2022
- Earnings Scheduled For February 23, 2022
Your note
Sign in to keep a note on NUVA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARRY JAMES CHRISTOPHER | Chief Executive Officer | Conversion of Exercise of derivative security | Feb 28, 2023 | 72,997 |
| CALAFIORE MASSIMO | Officer | Conversion of Exercise of derivative security | Feb 28, 2022 | 7,207 |
| FARRINGTON MICHAEL | Officer | Conversion of Exercise of derivative security | Feb 28, 2023 | 3,117 |
| HARBAUGH MATTHEW K | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 28, 2023 | 10,522 |
| KADIA SIDDHARTHA | Director | Conversion of Exercise of derivative security | May 26, 2022 | 3,739 |
| NORWALK LESLIE V | Director | Conversion of Exercise of derivative security | May 31, 2022 | 3,095 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.80% | 8,809,702 | 380.23M | Mar 30, 2023 |
| Vanguard Group, Inc. (The) | 11.31% | 5,933,898 | 256.11M | Mar 30, 2023 |
| State Street Corporation | 4.09% | 2,143,319 | 92.51M | Mar 30, 2023 |
| Macquarie Group Limited | 4.08% | 2,142,030 | 92.45M | Mar 30, 2023 |
| Magnetar Financial LLC | 3.39% | 1,778,831 | 76.77M | Mar 30, 2023 |
| Dimensional Fund Advisors LP | 2.98% | 1,561,855 | 67.41M | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 7.55% | 3,953,828 | 170.65M | Feb 27, 2023 |
| Vanguard Total Stock Market Index Fund | 3.01% | 1,578,100 | 68.11M | Dec 30, 2022 |
| Vanguard Small-Cap Index Fund | 2.57% | 1,343,105 | 57.97M | Dec 30, 2022 |
| iShares Russell 2000 ETF | 2.19% | 1,146,964 | 49.50M | Feb 27, 2023 |
| Thrivent Mid Cap Stock Fund | 2.16% | 1,131,437 | 48.83M | Jan 30, 2023 |
| Delaware Group Equity Fds V-Small Cap Core Fund | 1.93% | 1,012,849 | 43.71M | Nov 29, 2022 |